Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings Guido GrassiFosca Quarti TrevanoGiuseppe Mancia Secondary Hypertension: Nervous System Mechanisms (M Wyss, Section Editor) 10 October 2019 Article: 90
Potential Contribution of Carotid Body-Induced Sympathetic and Renin-Angiotensin System Overflow to Pulmonary Hypertension in Intermittent Hypoxia Rodrigo IturriagaSebastian Castillo-Galán Pulmonary Hypertension (JR Klinger, Section Editor) 10 October 2019 Article: 89
Trends and Status of the Prevalence of Elevated Blood Pressure in Children and Adolescents in China: a Systematic Review and Meta-analysis Lulin WangLulu SongYoujie Wang Pediatric Hypertension (B Falkner, Section Editor) 10 October 2019 Article: 88
Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in Health Terry D. Hinds JrDavid E. Stec Mechanisms of Hypertension and Target-Organ Damage (JE Hall and ME Hall, Section Editors) 10 October 2019 Article: 87
Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder? Kevin S. ShahJames C. Fang Mechanisms of Hypertension and Target-Organ Damage (JE Hall and ME Hall, Section Editors) 10 October 2019 Article: 86
Legacy Effect in the Treatment of Hypertension: Persistent Cardiovascular Protection after Conclusion of Randomized Clinical Trials in Hypertension Giovanna GalloAllegra BattistoniMassimo Volpe Guidelines/Clinical Trials/Meta-Analysis (WJ Kostis, Section Editor) 10 October 2019 Article: 85
Measuring Blood Pressure: from Cuff to Smartphone Andrew BarszczykKang Lee Blood Pressure Monitoring and Management (J Cockcroft, Section Editor) 10 October 2019 Article: 84
From Clinical Trials to Bedside: the Use of Antihypertensives in Aged Individuals. Part 2: Approach to Treatment Michael E. ErnstEric J. MacLaughlin Antihypertensive Agents: Mechanisms of Drug Action (ME Ernst, Section Editor) 10 October 2019 Article: 83
From Clinical Trials to Bedside: the Use of Antihypertensives in Aged Individuals. Part 1: Evaluation and Evidence of Treatment Benefit Eric J. MacLaughlinMichael E. Ernst Antihypertensive Agents: Mechanisms of Drug Action (ME Ernst, Section Editor) 10 October 2019 Article: 82